Triple therapy helped type 1 patients improve glycemia

NEW ORLEANS – The addition of dapagliflozin to insulin and liraglutide in patients with type 1 diabetes resulted in a significant improvement in glycemia, results from a single-center randomized...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news